Paris-based Anoat Therapeutics raises €2 million Seed to develop novel therapies for Cystic Fibrosis

Published on June 19, 2023

Anoat Therapeutics, a preclinical stage biotech company specialized in Cystic Fibrosis (CF), today announces it has raised €2 million in Seed funding from AdBio partners, a venture capital company specialized in seed investments in life sciences startups.  This investment from the AFB FII fund stems from the AdBio-Inserm Transfert partnership announced in May 2022 to…

This content is for members only. Visit the site and log in/register to read.

The post Paris-based Anoat Therapeutics raises €2 million Seed to develop novel therapies for Cystic Fibrosis appeared first on EU-Startups.

Continue reading on website
Other news

Democratising access to pharmacy services – Interview with Nadeem Sarwar, Founder and CEO of Phlo Technologies

June 19, 2023
UK pharmacies are currently struggling to cope with supply chain fluctuations, spiralling operating costs, record workforce shortages, and the predicted closure of up to 3000 high street pharmacy branches by 2024. Phlo Technologies is a UK-based company building a digital pharmacy that delivers prescriptions directly to patients for both repeat and acute prescriptions. They are… This content is fo

Five Effective Ways to Foster a Culture of Emotional Intelligence in the Workplace

June 19, 2023
Intelligence has a new dimension in contemporary times. Intellect is no longer limited to academic excellence and business acumen. Today, to be successful, you also need emotional intelligence along with...